Hepatitis-C virus type 4, 5 and 6

Details Hepatitis-C virus type 4, 5 and 6 Hepatitis-C virus type 4, 5 and 6

2007-02-20

2008-07-22

Lucas, Zachariah (Department: 1648)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Amino acid sequence disclosed in whole or in part; or...

C424S185100, C424S192100, C424S228100, C530S300000, C530S350000, C530S402000, C530S403000, C435S004000, C435S007100, C514S002600

Reexamination Certificate

active

07402315

ABSTRACT:
The present invention relates to a polynucleic acid composition comprising or consisting of at least one polynucleic acid containing 8 or more contiguous nucleotides corresponding to a nucleotide sequence from the region spanning positions 417 to 957 of the Core/E1 region of HCV type 3; and/or the region spanning positions 4664 to 4730 of the NS3 region of HCV type 3; and/or the region spanning positions 4892 to 5292 of the NS3/4 region of HCV type 3; and/or the region spanning positions 8023 to 8235 of the NS5 region of the BR36 subgroup of HCV type 3a; and/or the coding region of HCV type 4a starting at nucleotide 379 in the core region; and/or the coding region of HCV type 4; and/or the coding region of HCV type 5, with said nucleotide numbering being with respect to the numbering of HCV nucleic acids as shown in Table 1, and with said polynucleic acids containing at least one nucleotide difference with known HCV type 1, and/or HCV type 2 genomes in the above-indicated regions, or the complement thereof.

REFERENCES:
patent: 5302507 (1994-04-01), Chiba et al.
patent: 42 09 215 (1992-03-01), None
patent: 0 318-216 (1989-05-01), None
patent: 0 518 313 (1992-12-01), None
patent: WO 94/25601 (1994-11-01), None
patent: WO 95/11918 (1995-05-01), None
Huang et al., “Recent development of therapeutics for chronic HCV infection ,” Antiviral Research, vol. 71 Nos. 2-3, pp. 351-362 (Sep. 2006).
Leroux-Roels, “Development of prophylactic and therapeutic vaccines against hepatitis C virus,” Expert REview of Vaccines, vol. 4 No. 3, pp. 351-371 (Jun. 2005).
Wintermeyer et al., “Vaccines to prevent chronic hepatitis C virus infection: current experimental and preclinical developments ,” Journal of Gastroenterology, vol. 42 No. 6, pp. 424-432 (Jun. 2007).
GenPept Accession ABC58484, “non-structural protein 4b [Hepatitis C virus],” (May 2006).
Cha, T.A., et al., “At Lease Five Related, But Distinct, Hepatitis C Viral Genotypes Exist,”Proc. Natl. Acad. Sci. USA, Aug. 1, 1992, pp. 7144-7148, vol. 89, No. 15.
Chan, S. W., et al., “Analysis of a New Hepatitis C Virus Type and Its Phylogenetic Relationship to Existing Variants,”Journal of General Virology, 1992, pp. 1131-1141, vol. 73.
Farci, P., et al., “Immunity Elicited by Hepatitis C. Virus,”Gastroenterology, Apr. 1993, pp. 1228-1229, vol. 104, No. 4.
Marguerite, M., et al., “Analysis of Antigenicity and Immunogenicity of Five Different Chemically Defined Constructs of a Peptide,”Mol. Immunol., Jun. 1992, pp. 793-800, vol. 29, No. 6.
Prince, A.M., “Challenges for Development of Hepatitis C Virus Vaccines,”FEMS Microbiol. Rev. , Jul. 1994, pp. 273-277, vol. 14, No. 3.
Simmonds, P., et al., “Sequence Variability in the 5′ Non-coding Region of Hepatitis C Virus: Identification of a new Virus Type and Restrictions on Sequence Diversity,”Journal of General Virology, 1993, pp. 661-668, vol. 74.
Simmonds, P., et al., “Classification of Hepatitis C Virus Into Six Major Genotypes and a Series of Subtypes by Phylogenetic Analysis of the NS-5 Region,”Journal of General Virology, 1993, pp. 2391-2399, vol. 74.

Affiliated with

Also associated with

Rating

Hepatitis-C virus type 4, 5 and 6 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hepatitis-C virus type 4, 5 and 6, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hepatitis-C virus type 4, 5 and 6 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3971649